142 related articles for article (PubMed ID: 11279879)
21. Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: a respiratory chain dysfunction?
Brivet FG; Nion I; Mégarbane B; Slama A; Brivet M; Rustin P; Munnich A
J Hepatol; 2000 Feb; 32(2):364-5. PubMed ID: 10707883
[No Abstract] [Full Text] [Related]
22. Double "d" drug danger.
Moyle G
AIDS Read; 2003 Jan; 13(1):15-6, 23-4. PubMed ID: 12569891
[No Abstract] [Full Text] [Related]
23. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
Shah SS; Rodriguez T; McGowan JP
Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
[TBL] [Abstract][Full Text] [Related]
24. [Lipodystrophy in a patient treated with stavudine and didanosine].
Ruel M; Chemlal K; Melchior JC
Ann Med Interne (Paris); 1999 Apr; 150(3):269-71. PubMed ID: 10445099
[No Abstract] [Full Text] [Related]
25. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
[TBL] [Abstract][Full Text] [Related]
26. Extended warning on Didanosine-related pancreatitis.
Res Initiat Treat Action; 1999 Dec; 5(5):22-3. PubMed ID: 11366889
[TBL] [Abstract][Full Text] [Related]
27. Fatal lactic acidosis during antiretroviral therapy.
Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
[TBL] [Abstract][Full Text] [Related]
28. Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.
Reynes J; Denisi R; Massip P; Izopet J; Pellegrin I; Segondy M
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):103-5. PubMed ID: 10534154
[No Abstract] [Full Text] [Related]
29. Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication.
Sarner L; Fakoya A
Sex Transm Infect; 2002 Feb; 78(1):58-9. PubMed ID: 11872862
[TBL] [Abstract][Full Text] [Related]
30. [A very, very short of breath HIV-infected patient].
Mégarbane B; Fromont C; Nion I; Chary I; Axler O; Slama A; Brivet M; Rustin P; Munnich A; Brivet F
Rev Med Interne; 1999; 20 Suppl 2():256s-259s. PubMed ID: 10422161
[No Abstract] [Full Text] [Related]
31. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
[TBL] [Abstract][Full Text] [Related]
32. L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.
Claessens YE; Cariou A; Chiche JD; Dauriat G; Dhainaut JF
AIDS; 2000 Mar; 14(4):472-3. PubMed ID: 10770558
[No Abstract] [Full Text] [Related]
33. Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
Glesby MJ; Gerber JG
AIDS Read; 2003 Jul; 13(7):346-7. PubMed ID: 12889453
[No Abstract] [Full Text] [Related]
34. Safety of stavudine during pregnancy.
Blanche S
J Infect Dis; 2005 May; 191(9):1567-8; author reply 1568-9. PubMed ID: 15809919
[No Abstract] [Full Text] [Related]
35. New questions about an old combination--ddI + d4T.
Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
[TBL] [Abstract][Full Text] [Related]
36. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.
Wade NA; Unadkat JD; Huang S; Shapiro DE; Mathias A; Yasin S; Ciupak G; Watts DH; Delke I; Rathore M; Hitti J; Frenkel L; Samelson R; Smith ME; Mofenson L; Burchett SK
J Infect Dis; 2004 Dec; 190(12):2167-74. PubMed ID: 15551216
[TBL] [Abstract][Full Text] [Related]
40. Severe metabolic acidosis and Fanconi syndrome during stavudine and abacavir therapy in a resource-limited setting.
Bansie RD; Vreden SG
Braz J Infect Dis; 2012; 16(6):610-1. PubMed ID: 23141987
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
